Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Stabilization of Notch1 and β-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasis. | Transl Oncol | 2022 | 35339029 | PubTator, text mining | PubMed |
| Clueless/CLUH regulates mitochondrial fission by promoting recruitment of Drp1 to mitochondria. | Nat Commun | 2022 | 35332133 | PubTator, text mining | PubMed |
| Notch signaling pathway: architecture, disease, and therapeutics. | Signal Transduct Target Ther | 2022 | 35332121 | PubTator, text mining | PubMed |
| The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease. | Genes (Basel) | 2022 | 35328067 | PubTator, text mining | PubMed |
| Population Dynamics of Epithelial-Mesenchymal Heterogeneity in Cancer Cells. | Biomolecules | 2022 | 35327538 | PubTator, text mining | PubMed |
| Correction: Numb Promotes Cell Proliferation and Correlates with Poor Prognosis in Hepatocellular Carcinoma. | PLoS One | 2022 | 35320325 | PubTator, text mining | PubMed |
| GIT1 protects against breast cancer growth through negative regulation of Notch. | Nat Commun | 2022 | 35318302 | PubTator, text mining | PubMed |
| Leveraging Substrate Stiffness to Promote Stem Cell Asymmetric Division via Mechanotransduction-Polarity Protein Axis and Its Bayesian Regression Analysis. | Rejuvenation Res | 2022 | 35316074 | PubTator, text mining | PubMed |
| Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets. | Blood Cancer J | 2022 | 35301276 | PubTator, text mining | PubMed |
| A general calculus of fitness landscapes finds genes under selection in cancers. | Genome Res | 2022 | 35301263 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma. | Cancer Manag Res | 2022 | 35283645 | PubTator, text mining | PubMed |
| Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. | Cancer Lett | 2022 | 35278613 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis. | Int J Mol Sci | 2022 | 35269992 | PubTator, text mining | PubMed |
| New Insights into the (A)Synchronicity of Diels-Alder Reactions: A Theoretical Study Based on the Reaction Force Analysis and Atomic Resolution of Energy Derivatives. | Molecules | 2022 | 35268648 | PubTator, text mining | PubMed |
| Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy. | Cancers (Basel) | 2022 | 35267473 | PubTator, text mining | PubMed |
| Research progress on RNA-binding proteins in breast cancer. | Oncol Lett | 2022 | 35261635 | PubTator, text mining | PubMed |
| Colorectal liver metastasis: molecular mechanism and interventional therapy. | Signal Transduct Target Ther | 2022 | 35246503 | PubTator, text mining | PubMed |
| Roles for the methyltransferase SETD8 in DNA damage repair. | Clin Epigenetics | 2022 | 35246238 | PubTator, text mining | PubMed |
Ferritinophagy-Mediated Ferroptosis and Activation of Keap1/Nrf2/HO-1 Pathway Were Conducive to EMT Inhibition of Gastric Cancer Cells in Action of 2,2'-Di-pyridineketone Hydrazone Dithiocarbamate Butyric Acid Ester. | Oxid Med Cell Longev | 2022 | 35237380 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=25